Results 81 to 90 of about 8,225 (217)
Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGF [PDF]
, 2012 Hemangiomas are tumors formed by hyper-proliferation of vascular endothelial cells. This is caused by elevated vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2 (VEGFR2).
Medici, Damian, Olsen, Bjorn Reino
core +2 more sources
Infantile hemangiomas (IHs) are the most benign vascular tumors of infancy. IHs occur in 10–12% of infants. They often appear within 1–4 weeks of life. Superficial lesions are bright red or “strawberry” in color, sharply demarcated papules, nodules or plaques. Deep lesions are of bluish hue and dome-shaped.
Ranthilaka R. Gammanpila, Eckart Haneke
openaire +2 more sources
Topical timolol for small infantile hemangioma: a new therapy option
The Turkish Journal of Pediatrics, 2012 The main characteristic of infantile hemangioma is that it grows rapidly after birth and mostly regresses spontaneously. It is a common practice for only a small part of the hemangioma to be treated, as they can be extremely disfiguring and ...
Anne Weissenstein +3 more
doaj
Acta Pediátrica de México, 2017 Las lesiones vasculares en lactantes y niños se clasifican principalmente en dos grupos: tumores y malformaciones vasculares. Los hemangiomas infantiles se encuentran dentro del grupo de tumores benignos junto con otros como el granuloma piógeno, hemangioendotelioma kaposiforme y el hemangioma en penacho. Sin embargo, los hemangiomas infantiles son los
Carolina Hernández-Zepeda +1 more
openaire +3 more sources
Cancer Medicine, Volume 15, Issue 2, February 2026.The meta‐analysis, involving with 96 patients, shows high overall response rate with favorable safety to use topical beta‐blockers for epidermal growth factor receptor inhibitors‐induced periungual side effects. Subgroups of lung cancer or solution formation had lower complete response rate, while tyrosine kinase inhibitor and female patients had ...
Po‐Kai Chan +2 more
wiley +1 more source
Kasabach-Merritt phenomenon and prenatal counseling: a case series. [PDF]
, 2016 Kasabach-Merritt phenomenon can be encountered in the perinatal period. No consensus exists regarding prenatal management. We report one prenatal case leading to therapeutic abortion and one neonatal case, successfully treated by a multimodal therapy ...
Beissel, A. +6 more
core +1 more source
eLife, 2019 Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma. Despite the clinical benefit of propranolol therapy in hemangioma, the mechanistic understanding of what drives this outcome is limited ...
Jeroen Overman +17 more
doaj +1 more source
Journal of Clinical Laboratory Analysis, Volume 40, Issue 4, February 2026.This graphical abstract illustrates the experimental design and key findings of the study on the role of mesenchymal stem cells (MSCs) and Notch signaling in diabetic foot ulcer (DFU) healing. The study involved five groups of BALB/c mice: Control, Model, MSCs Treatment, MSCs + Notch Inhibition, and MSCs + Notch Activation.
Feifei Li +6 more
wiley +1 more source
Propranolol Treatment in the Management of Infantile Hemangioma in Erbil, Iraq [PDF]
Iranian Journal of NeonatologyBackground: Infantile hemangioma is a common benign vascular tumor that affects up to 10% of infants. Propranolol, a beta-blocker, has been used as a promising treatment for infantile hemangioma, but its effectiveness remains controversial.
Wesam Boya Kaka +2 more
doaj +1 more source
Лечащий ВрачBackground. Infantile (infantile) hemangiomas are benign vascular tumors found predominantly in the pediatric population. Its presence can lead not only to aesthetic discomfort of the child, but also to gross functional disorders.
R. V. Saranyuk, T. A. Gosteva
doaj +1 more source